and the source from which the isolate was obtained. Further target gene mutations were detected in single isolates: (i) a mutation that resulted in the Glu471Asp exchange in GrlB was present in an avian ST5 MRSA; (ii) a mutation at codon 517 in the gyrB gene (resulting in an Arg to Lys exchange) was found in the ST1791 MRSA of turkey meat origin; and (iii) the ST2269 isolate had an additional grlA mutation at codon 84 that caused a Glu to Asp exchange, and a gyrA mutation that resulted in a Glu88Asp exchange. The GrlA alterations Ser80Leu and Glu84Asp and the GyrA exchange Glu88Asp have not been identified so far in S. aureus. The role in fluoroquinolone resistance of the Glu422Asp exchange in GrlB needs further investigation as the corresponding mutation was present along with other mutations in staphylococci that varied in their enrofloxacin MICs between 1 and 8 mg/L, but it was also the only mutation detected in two porcine MRSA isolates with an enrofloxacin MIC of 1 mg/L. All but one of the MRSA and MSSA isolates investigated in this study showed one of two types of point mutations (A and B in Figure S1 , available as Supplementary data at JAC Online) in the norA promoter region; these, however, affected neither the 235 and 210 positions, nor the norA-associated ribosome binding site. For one avian MSSA isolate, no norA-specific PCR product could be obtained in repeated attempts.
The results of this study show that increased MICs of enrofloxacin among MRSA and MSSA isolates from diseased foodproducing animals or food of animal origin is mainly mediated by grlA and/or gyrA mutations, which-aside from the four novel mutations detected during this study-correspond to those reported previously in S. aureus isolates of different origin. 2 
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None to declare. Figure S1 is available as Supplementary data at JAC Online (http://jac. oxfordjournals.org/). Sir, Carbapenems are one of the most critically important antimicrobials considered as drugs of last choice in clinical settings. However, during the last few years, the prevalence of resistance to these antimicrobial agents, especially in Pseudomonas and Enterobacteriaceae, has been increasing worldwide. 1 -3 In Gram-negative bacteria, the mechanisms of resistance include the production of b-lactamases (carbapenemases), changes in the permeability of the membranes (i.e. loss of porins) and efflux pumps. Within the carbapenemases, the class B metallo-b-lactamases, such as VIM, IMP and NDM, play an important role because of their worldwide spread among different bacterial species, which is based on their location on mobile genetic elements. 2, 4, 5 Currently, the national RESET project (www.reset-verbund.de) performs several longitudinal and cross-sectional studies of German farms, and potential extended spectrum b-lactamase (ESBL)-carrier organisms are collected (using MacConkey agar containing 1 mg/L cefotaxime as selective medium). All isolates sent to the Federal Institute for Risk Assessment for further analyses (n¼ 221) were tested for their antimicrobial susceptibility by the CLSI disc diffusion method (CLSI M2-A10 and M100-S21). They were analysed against a panel of 17 b-lactams (Oxoid, Wesel, Germany), including ampicillin (10 mg), piperacillin (100 and 30 mg), ticarcillin (75 mg), cefalotin (30 mg), cefuroxime (30 mg), ceftiofur (30 mg), ceftriaxone (30 mg), ceftazidime (30 and 10 mg), cefotaxime (30 and 5 mg), cefpodoxime (10 mg), cefepime (30 mg), cefoxitin (30 mg), aztreonam (30 mg), imipenem (10 mg), ertapenem (10 mg), meropenem (10 mg) and amoxicillin/clavulanic acid (30 mg). The 30, 10 and 5 mg amounts for piperacillin, ceftazidime and cefotaxime, respectively, are the disc concentrations recommended by EUCAST (www.eucast.org). The isolates were also tested for their susceptibility to chloramphenicol (30 mg), florfenicol (30 mg), amikacin (30 mg), gentamicin (10 mg), kanamycin (30 mg), streptomycin (10 mg), spectinomycin (100 mg), nalidixic acid (30 mg), ciprofloxacin (5 mg), tetracycline (30 mg), trimethoprim (5 mg), sulfamethoxazole (300 mg), trimethoprim/sulfamethoxazole (1.25/23.75 mg) and colistin (10 mg). The results were interpreted using both CLSI clinical breakpoints (M100-S21) and, when available, the EUCAST epidemiological cut-off values (ECOFFs), which consider isolates with an acquired or mutational resistance mechanism to the drug in question as the non-wild-type population (www.eucast.org). In all isolates, the characterization of the b-lactamase-encoding genes bla TEM , bla OXA , bla CARB , bla CTX , bla SHV , bla ACC , bla CIT , bla DHA , bla EBC , bla FOX and bla MOX , additional resistance genes, and class 1 integrons was conducted as previously described. 6 The phylogenetic group, and for selected isolates the multilocus sequence type (MLST; http://mlst.ucc.ie/mlst/dbs/Ecoli), was also determined.
Supplementary data
One of the Escherichia coli isolates tested, R178, showed resistance to all penicillins, cephamycins, cephalosporins and amoxicillin/clavulanic acid, but was susceptible to aztreonam. R178 also showed a zone diameter of 22 mm for imipenem (intermediate by the CLSI clinical breakpoint and non-wild-type by the EUCAST ECOFF), 24 mm for ertapenem (susceptible by the CLSI clinical breakpoint and non-wild-type by the EUCAST ECOFF) and 25 mm for meropenem (susceptible by the CLSI clinical breakpoint and non-wild-type by the EUCAST ECOFF). It was also resistant to streptomycin and sulfamethoxazole (following the CLSI clinical breakpoints; for disc diffusion, no ECOFFs available). All these resistances could be transformed to an E. coli recipient (ElectroMax DH10B, Thermo Fischer). Both R178 and the transformant, T R178 , carried the AmpC b-lactamase-encoding gene bla ACC-1 , which confers cephalosporin and cephamycin resistance. The expression of this gene alone could not explain the zone diameter results observed for the three carbapenems, suggesting the presence of another mechanism. 2, 3 The positive results with the modified Hodge test, the double disc synergy test and the combined disc test using EDTA indicated the presence of a carbapenemase.
1 -3 Using a multiplex PCR targeting bla IMP , bla VIM and bla KPC genes and a single PCR for bla OXA-48 , 7 a fragment of 390 bp, which corresponded to bla VIM , was obtained. The sequence of a 748 bp bla VIM PCR fragment 8 indicated the presence of bla VIM-1 (accession no. AF191564). This fact was confirmed, as described below.
bla VIM genes have been found in different integrons (i.e. In31, In70, In110 and In450) and/or transposons (i.e. Tn3, Tn402 and Tn21). In fact, R178 carried a class 1 integron with a variable region of 2522 bp using the 5 ′ CS-3 ′ CS primers. 6 Within this variable region we detected bla VIM-1, aacA4 [also labelled aac(6 ′ )-Ib, amikacin/kanamycin resistance; not detected phenotypically in R178] and aadA1 [also labelled ant(3 ′′ )-Ia, streptomycin/spectinomycin resistance]. The integron also carried the qacED1 (quaternary ammonium compound resistance) and sul1 (sulphonamide resistance) genes in the 3 ′ conserved region. This integron, labelled In110, had been found in other enterobacteria, such as Klebsiella and Enterobacter cloacae, as well as in Pseudomonas in different South European countries. 5 The R178 integron and part of its genetic environment (5385 bp, Figure 1 ; accession no. HE663536) was sequenced (Eurofins MGW Operon, Ebersberg, Germany), indicating its insertion within Tn21 as previously described (accession no. GQ422826). 5 The bla VIM-1 genes have been found located on IncHI2, IncN, IncI1 and IncW plasmids in different hospital settings. 4, 5 In fact, the R178 class 1 integron was located on pRH-R178, a 220 kb IncHI2 plasmid (determined by S1-PFGE analyses and a PCR-based replicon scheme), 6 which also carried the bla ACC-1 and strA/B (streptomycin resistance) genes.
R178 was obtained during a longitudinal study in 2011 from a German pig farm holding 4100 pigs. The sample was taken, using gauze socks, from the corridor of a fattening unit with 5-month-old pigs. The R178 isolate was ascribed to ST88 and phylogenetic group A. Interestingly, other ST88 E. coli registered in the MLST database were obtained, among other sources, from chicken, cattle, turkeys and humans sampled in Germany as well. This is the first report on the presence of a carbapenemaseencoding gene in E. coli isolated from a livestock farm. How the isolate got there (colonized pig/environment/human) is not yet known. However, during the revision of this manuscript, we also detected bla VIM-1 in another E. coli isolated from faeces, 3 months before R178, on the same farm, indicating the animal carriage of the gene, integron and plasmid (data not shown). Also recently, Acinetobacter baumannii expressing OXA-23 isolated from cattle in France was reported. 9 The occurrence of ESBLs in Enterobacteriaceae (E. coli, Klebsiella and Salmonella) isolated from food-producing animals and the increase in their prevalence is a current problem worldwide, 6, 10 but until now the presence of carbapenemases seemed to be mainly restricted to humans. Taking into account the low expression of some carbapenemases and their affinity for different carbapenems (i.e. intermediate resistance to ertapenem, and decreased susceptibility for imipenem and meropenem) in some isolates, 2,3 the prevalence of carbapenemases in bacteria from livestock can be underestimated. Their level of expression could vary in vivo, 3 depending on the selective pressure (i.e. frequent use of carbapenems in hospital settings). In fact, in Germany carbapenems are not allowed for the treatment of livestock animals. The presence of carbapenemase-encoding genes located on highly effective mobile genetic elements in the livestock environment, and the possibility of their transmission via food in the community and/ or hospitals is worrying and an important issue for public health.
